Clinical Study
RyR2 QQ2958 Genotype and Risk of Malignant Ventricular Arrhythmias
Table 3
Genotypic frequency of the two analyzed polymorphisms in the study population and according to arrhythmias occurrence.
| | Total | Group I | Group II | value |
| RyR2 Q2958R (A>G) () | | | | | QQ | 18 (7.7%) | 14 (13.9%) | 4 (3.0%) | 0.0040 | QR | 213 (90.6%) | 85 (84.2%) | 128 (95.5%) | RR | 4 (1.7%) | 2 (1.9%) | 2 (1.5%) | HRC S96A (G>T) () | | | | | SS | 38 (16.2%) | 12 (11.9%) | 26 (19.4%) | 0.1750 | SA | 145 (61.7%) | 69 (68.3%) | 76 (56.7%) | AA | 52 (22.1%) | 20 (19.8%) | 32 (23.9%) |
|
|
with Fisher’s exact test, while using Armitage trend test.
|